Results 161 to 167 of about 8,127 (167)

Ribociclib in hormone-receptor-positive advanced breast cancer: Establishing a value-based cost in China

Breast, 2019
Xiaomin Wan, Xiaohui Zeng, Chongqing Tan   +2 more
exaly  

RIBOCICLIB TABLET

2016
COSTA RUI, GRANDEURY ARNAUD, GURURAJAN BINDHUMADHAVAN   +2 more
openaire   +7 more sources

Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication

Therapeutic Advances in Medical Oncology, 2019
Encarna Adrover, Xavier Gonzalez Farré, Juan Aguilar   +2 more
exaly  

MONALEESA Clinical Program: A Review of Ribociclib use in Different Clinical Settings

Future Oncology, 2019
Denise Yardley
exaly  

Development and validation of LC–MS/MS methods for the measurement of ribociclib, a CDK4/6 inhibitor, in mouse plasma and Ringer’s solution and its application to a cerebral microdialysis study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2017
Ashish Kala, Clinton Stewart, Yogesh Patel   +2 more
exaly  

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Cancer Science, 2018
exaly  

A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial

Annals of Oncology
Seock-Ah Im, Huang Cs, M Ruiz Borrego
exaly